N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression*

Various cancers such as colorectal cancer (CRC) are associated with alterations in protein glycosylation. CRC cell lines are frequently used to study these (glyco)biological changes and their mechanisms. However, differences between CRC cell lines with regard to their glycosylation have hitherto been largely neglected. Here, we comprehensively characterized the N-glycan profiles of 25 different CRC cell lines, derived from primary tumors and metastatic sites, in order to investigate their potential as glycobiological tumor model systems and to reveal glycans associated with cell line phenotypes. We applied an optimized, high-throughput membrane-based enzymatic glycan release for small sample amounts. Released glycans were derivatized to stabilize and differentiate between α2,3- and α2,6-linked N-acetylneuraminic acids, followed by N-glycosylation analysis by MALDI-TOF(/TOF)-MS. Our results showed pronounced differences between the N-glycosylation patterns of CRC cell lines. CRC cell line profiles differed from tissue-derived N-glycan profiles with regard to their high-mannose N-glycan content but showed a large overlap for complex type N-glycans, supporting their use as a glycobiological cancer model system. Importantly, we could show that the high-mannose N-glycans did not only occur as intracellular precursors but were also present at the cell surface. The obtained CRC cell line N-glycan features were not clearly correlated with mRNA expression levels of glycosyltransferases, demonstrating the usefulness of performing the structural analysis of glycans. Finally, correlation of CRC cell line glycosylation features with cancer cell markers and phenotypes revealed an association between highly fucosylated glycans and CDX1 and/or villin mRNA expression that both correlate with cell differentiation. Together, our findings provide new insights into CRC-associated glycan changes and setting the basis for more in-depth experiments on glycan function and regulation.

[1]  K. Khoo,et al.  Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116. , 2008, Glycobiology.

[2]  E. Miyoshi,et al.  Fucosylation and gastrointestinal cancer. , 2010, World journal of hepatology.

[3]  M. Engelse,et al.  Activation of human endothelial cells by tumor necrosis factor‐α results in profound changes in the expression of glycosylation‐related genes , 2006, Journal of cellular physiology.

[4]  F. dall’Olio,et al.  UDP-GalNAc:NeuAc alpha 2,3Gal beta-R (GalNAc to Gal) beta 1,4-N-acetylgalactosaminyltransferase responsible for the Sda specificity in human colon carcinoma CaCo-2 cell line. , 1991, Biochemical and biophysical research communications.

[5]  B Drewinko,et al.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. , 1976, Cancer research.

[6]  W. Koltun,et al.  Primary cell lines: false representation or model system? a comparison of four human colorectal tumors and their coordinately established cell lines. , 2010, International journal of clinical and experimental medicine.

[7]  L. McDonnell,et al.  N-glycosylation of Colorectal Cancer Tissues , 2012, Molecular & Cellular Proteomics.

[8]  R. Hay,et al.  Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. , 1983, Cancer genetics and cytogenetics.

[9]  D. Santini,et al.  Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. , 2007, Glycobiology.

[10]  Y. van Kooyk,et al.  Highly glycosylated tumour antigens: interactions with the immune system. , 2011, Biochemical Society transactions.

[11]  K. Lam,et al.  Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling. , 2014, Journal of proteome research.

[12]  C. Sander,et al.  Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.

[13]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[14]  Pauline M Rudd,et al.  Glycans as cancer biomarkers. , 2012, Biochimica et biophysica acta.

[15]  I. Lai,et al.  β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer. , 2014, Carcinogenesis.

[16]  Yehia Mechref,et al.  Identifying cancer biomarkers by mass spectrometry‐based glycomics , 2012, Electrophoresis.

[17]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[18]  J. Gu,et al.  A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. , 2009, Journal of proteome research.

[19]  Peng Gao,et al.  Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. , 2013, Analytical chemistry.

[20]  Magnus Palmblad,et al.  MassyTools: A High-Throughput Targeted Data Processing Tool for Relative Quantitation and Quality Control Developed for Glycomic and Glycoproteomic MALDI-MS. , 2015, Journal of proteome research.

[21]  S. Rockwell In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer. , 1980, The British journal of cancer. Supplement.

[22]  R. Christopherson,et al.  Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies. , 2014, Journal of proteomics.

[23]  Y. Rombouts,et al.  Glycosylation characteristics of colorectal cancer. , 2015, Advances in cancer research.

[24]  N. Packer,et al.  Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. , 2014, Journal of proteome research.

[25]  R. Sandberg,et al.  Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Chen,et al.  DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin. , 1995, Cancer genetics and cytogenetics.

[27]  Ying Liu,et al.  Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1 , 2009, Proceedings of the National Academy of Sciences.

[28]  W. Bodmer,et al.  Cancer stem cells from colorectal cancer-derived cell lines , 2010, Proceedings of the National Academy of Sciences.

[29]  Raquel Chaves,et al.  The Importance of Cancer Cell Lines as in vitro Models in Cancer Methylome Analysis and Anticancer Drugs Testing , 2013 .

[30]  W. Bodmer,et al.  Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Manfred Wuhrer,et al.  Mass spectrometric glycan rearrangements. , 2011, Mass spectrometry reviews.

[32]  P. Rudd,et al.  Altered Glycosylation in Tumours Focused to Cancer Diagnosis , 2009, Disease markers.

[33]  Naoyuki Taniguchi,et al.  Functional roles of N‐glycans in cell signaling and cell adhesion in cancer , 2008, Cancer science.

[34]  E. Steenvoorden,et al.  2‐Picoline‐borane: A non‐toxic reducing agent for oligosaccharide labeling by reductive amination , 2010, Proteomics.

[35]  C. Haglund,et al.  N-glycomic Profiling as a Tool to Separate Rectal Adenomas from Carcinomas* , 2014, Molecular & Cellular Proteomics.

[36]  S. von Kleist,et al.  Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. , 1975, Journal of the National Cancer Institute.

[37]  André M Deelder,et al.  Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. , 2011, Analytical chemistry.

[38]  J. Garcia-Vallejo,et al.  Approach for defining endogenous reference genes in gene expression experiments. , 2004, Analytical biochemistry.

[39]  W. Bodmer,et al.  Cancer cell lines for drug discovery and development. , 2014, Cancer research.

[40]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[41]  Z. Li,et al.  Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.

[42]  H. Matsumoto,et al.  Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy , 2012, Biomolecules.

[43]  L. Aaltonen,et al.  Villin expression is frequently lost in poorly differentiated colon cancer. , 2012, The American journal of pathology.

[44]  R. Cummings,et al.  Antibodies and Lectins in Glycan Analysis , 2009 .

[45]  R. Kannagi,et al.  Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis , 2004, Cancer science.

[46]  Shuai Jiang,et al.  A novel lectin from Agrocybe aegerita shows high binding selectivity for terminal N-acetylglucosamine , 2012, The Biochemical journal.

[47]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[48]  V. Sandig,et al.  Rapid analysis of cell surface N-glycosylation from living cells using mass spectrometry. , 2014, Journal of proteome research.

[49]  M. Mortuaire,et al.  B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract. , 2014, The international journal of biochemistry & cell biology.

[50]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[51]  D. Schaffer,et al.  Extensive Determination of Glycan Heterogeneity Reveals an Unusual Abundance of High Mannose Glycans in Enriched Plasma Membranes of Human Embryonic Stem Cells* , 2011, Molecular & Cellular Proteomics.

[52]  Adam Ertel,et al.  Pathway-specific differences between tumor cell lines and normal and tumor tissue cells , 2006, Molecular Cancer.

[53]  R. Takimoto,et al.  Fucosylated TGF-β receptors transduces a signal for epithelial–mesenchymal transition in colorectal cancer cells , 2013, British Journal of Cancer.

[54]  S. Gringhuis,et al.  Gene expression analysis of glycosylation-related genes by real-time polymerase chain reaction. , 2006, Methods in molecular biology.

[55]  E. Suh,et al.  The role of Cdx proteins in intestinal development and cancer , 2004, Cancer biology & therapy.

[56]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[57]  F. dall’Olio,et al.  UDP-Ga1NAc:NeuAcα2,3Galβ-R (GaINAc to Gal) β1,4-N-acetyl-galactosaminyltransferase responsible for the Sda specificity in human colon carcinoma CaCo-2 cell line , 1991 .

[58]  Heather Lynaugh,et al.  A cost-effective plate-based sample preparation for antibody N-glycan analysis. , 2013, Journal of chromatography. A.

[59]  André M Deelder,et al.  High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. , 2014, Analytical chemistry.

[60]  A. Jemal,et al.  Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[61]  J. Morgado-Díaz,et al.  N‐glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells , 2012, Journal of cellular biochemistry.